Dr Lal Pathlabs. Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 2,45,047 shares,. Its Average Traded Price (ATP) is ₹1871.66, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹1859.90.
Dr Lal Pathlabs. has an upper circuit limit of ₹2231.80 and a lower circuit limit of ₹1488.00. The total value traded stands at ₹45.86 CR, and the delivery percentage for the day is 59.59%.
The stock is currently traded with a market lot size of 1. Dr Lal Pathlabs. also offers a dividend yield of 1.1%.
Dr Lal Pathlabs Share Price Chart
Dr Lal Pathlabs. Share Key Metrics
Volume
2.45 L
Market Cap
31218.20 CR
LTQ@LTP
6@1859.90
ATP
1871.66
Var Margin
14.76 %
Circuit Range
1488-2231.8
Delivery %
59.59 %
Value
45.86 CR
ASM/GSM
No
Market Lot
1
Dr Lal Pathlabs. Resistance and Support
Pivot 1892.9
Resistance
First Resistance
1929
Second Resistance
1972.9
Third Resistance
2009
Support
First Support
1849
Second Support
1812.9
Third Support
1769
Dr Lal Pathlabs. Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2025-26
- 2024-25
- 2022-23
- 2023-24
- 2026-27
Total Promoters
Dr Lal Pathlabs. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-07-24 | Quarterly Results |
| 2026-04-30 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results & Interim Dividend |
| 2025-10-31 | Qtr Results |
| 2025-07-31 | Quarterly Results |
| 2025-04-25 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
| 2024-10-23 | Quarterly Results & Interim Dividend |
| 2024-08-07 | Quarterly Results & Interim Dividend |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-30 | 2026-07-30 | View More |
| Bonus Date | Record Date | |
|---|---|---|
| 2025-10-31 | 2025-12-19 | View More |
Dr Lal Pathlabs. News
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Dr. Lal Path Labs has successfully completed the acquisition of a stake in SN Genelab Private Limited on October 01, 2026. The board had previously approved this transaction on September 24, 2026.
Oct 01 2026 19:32:36
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Dr. Lal Path Labs' wholly-owned subsidiary DLPL Dubai completed the acquisition of an 80% stake in Sunshine Healthcare Limited (SHL), Ghana. SHL becomes a step-down subsidiary of the company.
Sep 26 2026 16:55:33
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Intimation for The Quarter And Half Year Ending On September 30, 2026
Dr. Lal Path Labs board meeting scheduled for November 04, 2026. The board will consider and approve the financial results for Q2 and H1 FY27, ended September 30, 2026. This intimation was filed on September 25, 2026.
Sep 25 2026 18:06:36
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Acquisition
Dr. Lal Path Labs acquired a 70% stake in SN Genelab Private Limited, a genomics diagnostics company, for up to Rs. 199.5 crores. This strategic acquisition aims to strengthen the company's expertise in genomics and broaden its advanced diagnostic services portfolio. The transaction is expected to conclude by November 30, 2026.
Sep 24 2026 17:22:20
Dr. Lal PathLabs Ltd - 539524 - Board Meeting Outcome for Outcome Of Board Meeting Dated September 24, 2026
Dr. Lal Path Labs' Board has approved the acquisition of a 70% stake in SN Genelab Private Limited. This strategic move, valued at up to Rs. 199.5 crore, aims to enhance the company's genomics expertise and expand its portfolio of advanced diagnostic services. SN Genelab will become a subsidiary.
Sep 24 2026 17:20:57
Dr Lal Pathlabs. Management
| Name | Position |
|---|---|
| Vinay Gujral | Company Secretary & Compliance Officer |
| Arvind Lal | Chairman |
Dr Lal Pathlabs. Similar Stocks
Emcure Pharmaceuticals Ltd.
1820.60
-15.40 (0.84%)
Narayana Hrudayalaya Ltd.
1719.40
-6.00 (0.35%)
Global Health Ltd.
1240.00
-35.50 (2.78%)
Wockhardt Ltd.
1954.90
5.50 (0.28%)
Sai Life Sciences Ltd.
1389.40
-5.30 (0.38%)
Krishna Institute of Medical Sciences Ltd
685.60
-3.05 (0.44%)
Neuland Laboratories Ltd.
19675.00
-280.00 (1.40%)
Acutaas Chemicals Ltd.
3206.00
73.50 (2.35%)
Dr Lal Pathlabs. FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in LALPATHLAB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in LALPATHLAB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade